Literature DB >> 15001437

Depressed cardiac tension cost in experimental diabetes is due to altered myosin heavy chain isoform expression.

Veronica L M Rundell1, David L Geenen, Peter M Buttrick, Pieter P de Tombe.   

Abstract

Cardiac disease in diabetes presents as impaired left ventricular contraction and relaxation; however, the mechanisms underlying contractile protein dysfunction during the progression of disease are unknown. Accordingly, we assessed Ca(2+)-dependent tension development and tension-dependent ATP consumption (tension cost) in a rat model early (6 wk) and late (12 wk) after the onset of diabetes (50 mg/kg iv streptozotocin) using mechanical force- and enzyme-coupled UV absorbance measurements. Myofilament Ca(2+) sensitivity and maximal tension were unchanged between groups at either time point. Cross-bridge cycling rate was significantly decreased in diabetes, as indexed by tension cost (early control 5.4 +/- 0.4 and early diabetes 4.2 +/- 0.3; and late control 6.0 +/- 0.2 and late diabetes 4.2 +/- 0.2; P < 0.05). Because rodent models of cardiac disease are confounded by altered myosin isoform distribution, myosin content was determined by SDS-PAGE and densitometry. The cardiac content of alpha-myosin in diabetes was decreased to 41% +/- 4.1 at 6 wk and 32.5% +/- 2.9 at 12 wk of diabetes (early control 77.8% +/- 3.3 and late control 73.6% +/- 2.5). Separate control experiments demonstrated a linear decrease in tension cost with decreased alpha-myosin content. Given this, the depression of tension cost in this rodent model of diabetes could be fully explained by the altered myosin isoform distribution.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15001437     DOI: 10.1152/ajpheart.00049.2004

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  22 in total

1.  Ca2+-independent positive molecular inotropy for failing rabbit and human cardiac muscle by alpha-myosin motor gene transfer.

Authors:  Todd J Herron; Eric Devaney; Lakshmi Mundada; Erik Arden; Sharlene Day; Guadalupe Guerrero-Serna; Immanuel Turner; Margaret Westfall; Joseph M Metzger
Journal:  FASEB J       Date:  2009-10-02       Impact factor: 5.191

2.  Increased myocardial short-range forces in a rodent model of diabetes reflect elevated content of β myosin heavy chain.

Authors:  Charles S Chung; Mihail I Mitov; Leigh Ann Callahan; Kenneth S Campbell
Journal:  Arch Biochem Biophys       Date:  2013-09-04       Impact factor: 4.013

3.  Myosin heavy chain composition and the economy of contraction in healthy and diseased human myocardium.

Authors:  N A Narolska; S Eiras; R B van Loon; N M Boontje; R Zaremba; S R Spiegelen Berg; W Stooker; M A J M Huybregts; F C Visser; J van der Velden; G J M Stienen
Journal:  J Muscle Res Cell Motil       Date:  2005-10-14       Impact factor: 2.698

4.  Altered tension cost in (TG(mREN-2)27) rats overexpressing the mouse renin gene.

Authors:  Carsten Zobel; Persephone Zavidou-Saroti; Birgit Bölck; Klara Brixius; Hannes Reuter; Konrad Frank; Holger Diedrichs; Jochen Müller-Ehmsen; Wilhelm Bloch; Robert H G Schwinger
Journal:  Eur J Appl Physiol       Date:  2006-10-25       Impact factor: 3.078

Review 5.  Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathy.

Authors:  Mark T Waddingham; Amanda J Edgley; Hirotsugu Tsuchimochi; Darren J Kelly; Mikiyasu Shirai; James T Pearson
Journal:  World J Diabetes       Date:  2015-07-10

6.  Role of myosin heavy chain composition in the stretch activation response of rat myocardium.

Authors:  Julian E Stelzer; Stacey L Brickson; Matthew R Locher; Richard L Moss
Journal:  J Physiol       Date:  2006-11-30       Impact factor: 5.182

7.  Myosin heads are displaced from actin filaments in the in situ beating rat heart in early diabetes.

Authors:  Mathew J Jenkins; James T Pearson; Daryl O Schwenke; Amanda J Edgley; Takashi Sonobe; Yutaka Fujii; Hatsue Ishibashi-Ueda; Darren J Kelly; Naoto Yagi; Mikiyasu Shirai
Journal:  Biophys J       Date:  2013-03-05       Impact factor: 4.033

8.  Assist devices fail to reverse patterns of fetal gene expression despite beta-blockers.

Authors:  Brian D Lowes; Ronald Zolty; Simon F Shakar; Andreas Brieke; Norman Gray; Michael Reed; Mihail Calalb; Wayne Minobe; JoAnn Lindenfeld; Eugene E Wolfel; Mark Geraci; Michael R Bristow; Joseph Cleveland
Journal:  J Heart Lung Transplant       Date:  2007-11       Impact factor: 10.247

9.  The CAAT-binding transcription factor 1/nuclear factor 1 binding site is important in beta-myosin heavy chain antisense promoter regulation in rats.

Authors:  Julia M Giger; Paul W Bodell; Kenneth M Baldwin; Fadia Haddad
Journal:  Exp Physiol       Date:  2009-08-14       Impact factor: 2.969

10.  Length-dependent effects on cardiac contractile dynamics are different in cardiac muscle containing α- or β-myosin heavy chain.

Authors:  Steven J Ford; Murali Chandra
Journal:  Arch Biochem Biophys       Date:  2012-10-27       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.